BPC-157 + TB-500 (Blend)

BPC-157 + TB-500 (10mg Blend)

This blend contains two research-grade peptides—BPC-157 and TB-500—combined in a single lyophilized vial for controlled laboratory studies investigating complementary biochemical pathways. BPC-157 has been examined in peer-reviewed literature, including mechanistic findings referenced under PubMed ID: 25924990, describing its influence on angiogenic and cytoprotective pathways. TB-500, a synthetic analog of thymosin beta-4, is widely used to study actin-binding protein interactions, cytoskeletal organization, and cellular migration processes.

When used together in mechanistic research models, this combination provides a unique tool for examining multi-pathway interactions involving fibroblast signaling, extracellular matrix dynamics, nitric oxide modulation, actin organization, and peptide-mediated cytoprotective processes. The blend format ensures consistent composition for in-vitro biochemical assays and pathway mapping studies where coordinated peptide activity is of investigative interest.